logo-loader
Acasti Pharma Inc

Full interview: Acasti Pharma signs long term deal with Aker Bio Marine to deliver Krill Oil

Acasti Pharma  (CVE: ACST) Chief Operations and Scientific Officer Pierre Lemieux joined Steve Darling to discuss the company signing a long term deal to a have a consistent supply of the Krill Oil which is critical in the development of their flagship product CaPre.

Lemieux discussing what it means to have a consistent supply and how a fixed price over the term really helps Acasti in planning and costs.
 

Quick facts: Acasti Pharma Inc

Price: 2.8 CAD

Market: TSX-V
Market Cap: $238.91 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Acasti Pharma Inc named herein, including the promotion by the Company of Acasti Pharma Inc in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Acasti Pharma receives $750,000 grant from National Research...

Acasti Pharma (CVE: ACST) Co-founder COO and Chief Scientific Officer Dr, Pierre Lemieux joined Steve Darling from Proactive Vancouver on Skype to discuss the company has received a sizable grant from the Canadian Government to help their drug development work. Lemieux telling Proactive what...

on 9/9/19

2 min read